Else-Kröner Strasse 1
Bad Homburg , 61352
Bad Homburg , 61352
News
-
Fresenius Medical Care increased 0.4% to €27.71 after the dialysis service provider lifted its annual outlook.
Revenue in the third quarter declined 3% to €4.9 billion from €5.03 billion, net income fell to €84 million from €230 million, and net income dropped to 29 cents from 7 cents a year ago.
The company reiterated its 2023 revenue to grow at a low to mid-single-digit percentage rate from €19.4 billion in 2022.
The company raised its 2023 operating earnings to grow at a low single-digit percentage rate from €1.54 billion in 2022, from the More
Nov 22, 2023 -
Fresenius Medical SE increased 6.9% to €27.21 after the German dialysis company reported adjusted earnings that were ahead of expectations.
Revenue in the first quarter increased 3.4% to €4.7 billion and net income fell 45.1% to €86 million from €157 million and basic earnings per share declined to 29 cents from 54 cents a year ago.
Adjusted earnings per share, which excludes the U.S. Provider Relief Funding and Ukraine war related items among other adjustments, declined to 53 cents from 67 cents a year ago.
Fresenius forecasted 2 More
May 9, 2023
Executive/
Director
Links
Price
- Last Close
-
$ 22.38
$ +0.24 1.08 %
Jan 3, 2025
- 52-Week High/Low
- $23.96 - $16.4
- YTD
- -1.1%
- Trading Volume
- 7,284
- Market Cap Full
- $ 6.6B
- Shares Outstanding
-
293.4M
Dec 31, 2022
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | 5.4% | -0.2% | -2.8% | 25.1% | -5% | -11.3% | 3.8% | 30.1% | -7.4% | -1.1% |
| Q2 | -0.1% | 16% | 1.2% | -3.6% | 4% | 12.7% | -26% | 12.5% | 0.5% | - |
| Q3 | 0.5% | 1.2% | 2.8% | -15.8% | 8% | -15.9% | -43.7% | -10% | 0.4% | - |
| Q4 | -3.6% | 6.3% | -38.7% | 9.5% | -2.2% | -7.2% | 16.4% | -2.2% | -5.7% | - |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -1.1% | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | -7.4% | -0.4% | 0.4% | 6.6% | 3.5% | -9.9% | 0.6% | 0.4% | - | - | - | - |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14% | 2% | 26% | -38% | 13% | 13% | -22% | -50% | 28% | 9% | -1% |
Earnings
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Q1 | 0.37 | 0.53 | 0.56 | 0.5 | 0.52 | 0.51 | 0.3 | 0.16 |
| Q2 | 0.48 | 0.48 | 1.94 | 0.47 | 0.66 | 0.45 | 0.27 | 0.26 |
| Q3 | 0.54 | 0.59 | 0.54 | 0.61 | 0.71 | 0.55 | 0.39 | 0.16 |
| Q4 | 0.63 | 0.69 | 0.77 | 0.64 | 0.37 | 0.44 | 0.25 | - |
| A | 2 | 2.3 | 3.8 | 2.2 | 2.3 | 2 | 1.21 | 0.58 |
Annual Returns
52 Week
High/Low
Annual
Earnings
Chart
Trading Volume
Dividend +
Dividend +
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Q1 | 0.50 | 0.57 | 0.49 | 0.42 | 0.44 |
| Q2 | - | - | - | - | - |
| Q3 | - | - | - | - | - |
| Q4 | - | - | - | - | - |
| A | 0.5 | 0.57 | 0.49 | 0.42 | 0.44 |
Outstanding Shares
(In Millions) +
Jan 16, 2024
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Mar | 306.1 | - | - | - | - |
| Jun | 306.1 | - | - | - | - |
| Sep | 306.8 | - | - | - | - |
| Dec | 306.9 | 298.3 | 292.9 | 293 | 293.4 |
Annual
SEC Filings
Financial Ratios
| 2022 | 2021 | 2020 | 2019 | 2018 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Management | ||||||||||||||||||
| Inventory / Stock Turnover | 6.1 | 6.2 | 6.5 | 7.3 | 7.8 | |||||||||||||
| Fixed Asset Turnover | 3.4 | 3 | 3.2 | 3.1 | 3.2 | |||||||||||||
| Total Asset Turnover | 0.5 | 0.5 | 0.6 | 0.5 | 0.6 | |||||||||||||
| Leverage | ||||||||||||||||||
| Debt Ratio | 0.9 | 0.8 | 0.9 | 0.9 | 0.6 | |||||||||||||
| Debt – Equity Ratio | 0.5 | 0.5 | 0.6 | 0.5 | 0.4 | |||||||||||||
| Interest Coverage | 1.8 | 2.1 | 2 | 2.1 | 2.9 | |||||||||||||
| Equity multiplier | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | |||||||||||||